questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CXC
Chimiokines CXC : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Chimiokines
Tests de laboratoire
Maladies auto-immunes
Inflammation
Biopsie
Immunohistochimie
Symptômes
5
Système nerveux
Inflammation cérébrale
Psoriasis
Maladies cutanées
Maladies inflammatoires de l'intestin
Symptômes digestifs
Prévention
5
Hygiène de vie
Gestion du stress
Alimentation
Antioxydants
Exercice physique
Santé immunitaire
Stress chronique
Inflammation
Traitements
5
Thérapies biologiques
Inhibiteurs
Corticostéroïdes
Inflammation
Traitements anti-inflammatoires
Symptômes inflammatoires
Essais cliniques
Traitements
Complications
5
Maladies auto-immunes
Infections chroniques
Cicatrisation
Inflammation
Maladies cardiovasculaires
Risque
Sclérose en plaques
Alzheimer
Facteurs de risque
5
Infections
Expression génique
Vieillissement
Inflammation
Diabète
Maladies métaboliques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokines CXC : Questions médicales les plus fréquentes",
"headline": "Chimiokines CXC : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokines CXC : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-09",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chimiokines",
"url": "https://questionsmedicales.fr/mesh/D018925",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines",
"code": {
"@type": "MedicalCode",
"code": "D018925",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL1",
"alternateName": "Chemokine CXCL1",
"url": "https://questionsmedicales.fr/mesh/D054360",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL1",
"code": {
"@type": "MedicalCode",
"code": "D054360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL16",
"alternateName": "Chemokine CXCL16",
"url": "https://questionsmedicales.fr/mesh/D000075743",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL16",
"code": {
"@type": "MedicalCode",
"code": "D000075743",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL5",
"alternateName": "Chemokine CXCL5",
"url": "https://questionsmedicales.fr/mesh/D054365",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL5",
"code": {
"@type": "MedicalCode",
"code": "D054365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL6",
"alternateName": "Chemokine CXCL6",
"url": "https://questionsmedicales.fr/mesh/D054427",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL6",
"code": {
"@type": "MedicalCode",
"code": "D054427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL9",
"alternateName": "Chemokine CXCL9",
"url": "https://questionsmedicales.fr/mesh/D054370",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL9",
"code": {
"@type": "MedicalCode",
"code": "D054370",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL10",
"alternateName": "Chemokine CXCL10",
"url": "https://questionsmedicales.fr/mesh/D054357",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL10",
"code": {
"@type": "MedicalCode",
"code": "D054357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL11",
"alternateName": "Chemokine CXCL11",
"url": "https://questionsmedicales.fr/mesh/D054371",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL11",
"code": {
"@type": "MedicalCode",
"code": "D054371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL12",
"alternateName": "Chemokine CXCL12",
"url": "https://questionsmedicales.fr/mesh/D054377",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL12",
"code": {
"@type": "MedicalCode",
"code": "D054377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL13",
"alternateName": "Chemokine CXCL13",
"url": "https://questionsmedicales.fr/mesh/D054382",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL13",
"code": {
"@type": "MedicalCode",
"code": "D054382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-4 plaquettaire",
"alternateName": "Platelet Factor 4",
"url": "https://questionsmedicales.fr/mesh/D010978",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4 plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D010978",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC",
"alternateName": "Chemokines, CXC",
"code": {
"@type": "MedicalCode",
"code": "D019743",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Amin Ullah",
"url": "https://questionsmedicales.fr/author/Amin%20Ullah",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Bairong Shen",
"url": "https://questionsmedicales.fr/author/Bairong%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Gholamhossein Hassanshahi",
"url": "https://questionsmedicales.fr/author/Gholamhossein%20Hassanshahi",
"affiliation": {
"@type": "Organization",
"name": "Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Dept. of Hematology, Faculty of Biomed, Biomedical Sciences, Kerman University of Medical Sciences, Kerman, Iran."
}
},
{
"@type": "Person",
"name": "Mojgan Noroozi Karimabad",
"url": "https://questionsmedicales.fr/author/Mojgan%20Noroozi%20Karimabad",
"affiliation": {
"@type": "Organization",
"name": "Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: mojgan.noroozi@yahoo.com."
}
},
{
"@type": "Person",
"name": "Tracy M Handel",
"url": "https://questionsmedicales.fr/author/Tracy%20M%20Handel",
"affiliation": {
"@type": "Organization",
"name": "Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Speech intelligibility changes the temporal evolution of neural speech tracking.",
"datePublished": "2023-01-21",
"url": "https://questionsmedicales.fr/article/36693596",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuroimage.2023.119894"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Transparent Mask and Clear Speech Benefit Speech Intelligibility in Individuals With Hearing Loss.",
"datePublished": "2023-10-03",
"url": "https://questionsmedicales.fr/article/37788660",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_JSLHR-22-00636"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vowel Acoustics as Predictors of Speech Intelligibility in Dysarthria.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36795536",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00287"
}
},
{
"@type": "ScholarlyArticle",
"name": "ASR-based speech intelligibility prediction: A review.",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36154977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heares.2022.108606"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lexical Predictors of Intelligibility in Young Children's Speech.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36626389",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00294"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CXC",
"item": "https://questionsmedicales.fr/mesh/D019743"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokines CXC - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokines CXC",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokines CXC",
"description": "Comment diagnostiquer une dysrégulation des chimiokines CXC ?\nQuels tests sont utilisés pour mesurer les chimiokines CXC ?\nLes chimiokines CXC sont-elles liées à des maladies spécifiques ?\nPeut-on détecter les chimiokines CXC dans les biopsies ?\nLes niveaux de chimiokines CXC varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Speech+Intelligibility#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokines CXC",
"description": "Quels symptômes sont associés à une surproduction de chimiokines CXC ?\nLes chimiokines CXC peuvent-elles causer des symptômes respiratoires ?\nComment les chimiokines CXC affectent-elles le système nerveux ?\nLes chimiokines CXC sont-elles liées à des symptômes cutanés ?\nPeut-on observer des symptômes digestifs liés aux chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Speech+Intelligibility#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokines CXC",
"description": "Peut-on prévenir les maladies liées aux chimiokines CXC ?\nL'alimentation influence-t-elle les chimiokines CXC ?\nL'exercice physique affecte-t-il les niveaux de chimiokines CXC ?\nLe tabagisme influence-t-il les chimiokines CXC ?\nLe stress chronique affecte-t-il les chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Speech+Intelligibility#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokines CXC",
"description": "Quels traitements ciblent les chimiokines CXC ?\nLes corticostéroïdes affectent-ils les chimiokines CXC ?\nComment les inhibiteurs de chimiokines CXC fonctionnent-ils ?\nLes traitements anti-inflammatoires influencent-ils les chimiokines CXC ?\nY a-t-il des essais cliniques sur les chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Speech+Intelligibility#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokines CXC",
"description": "Quelles complications peuvent survenir avec des niveaux élevés de chimiokines CXC ?\nLes chimiokines CXC sont-elles impliquées dans le cancer ?\nComment les chimiokines CXC affectent-elles la cicatrisation des plaies ?\nLes maladies cardiovasculaires sont-elles liées aux chimiokines CXC ?\nLes chimiokines CXC peuvent-elles causer des troubles neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Speech+Intelligibility#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokines CXC",
"description": "Quels facteurs de risque augmentent les niveaux de chimiokines CXC ?\nLes infections peuvent-elles influencer les chimiokines CXC ?\nL'exposition à des polluants affecte-t-elle les chimiokines CXC ?\nLe vieillissement influence-t-il les chimiokines CXC ?\nLes maladies métaboliques sont-elles liées aux chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Speech+Intelligibility#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des chimiokines CXC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines peuvent aider à évaluer les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les chimiokines CXC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages ELISA et les tests multiplex sont couramment utilisés pour mesurer les chimiokines."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles liées à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent associées à des maladies inflammatoires et auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les chimiokines CXC dans les biopsies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chimiokines peuvent être détectées dans les tissus par immunohistochimie."
}
},
{
"@type": "Question",
"name": "Les niveaux de chimiokines CXC varient-ils selon l'âge ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de chimiokines peuvent varier avec l'âge et l'état de santé général."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une surproduction de chimiokines CXC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent inflammation, douleur, fatigue et troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC peuvent-elles causer des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans des maladies respiratoires comme l'asthme et la BPCO."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CXC affectent-elles le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à des troubles neurologiques en modulant l'inflammation cérébrale."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles liées à des symptômes cutanés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être impliquées dans des maladies cutanées inflammatoires comme le psoriasis."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes digestifs liés aux chimiokines CXC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent jouer un rôle dans des maladies inflammatoires de l'intestin."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux chimiokines CXC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène de vie et la gestion du stress peuvent aider à prévenir certaines maladies."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les chimiokines CXC ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut réduire l'inflammation et les chimiokines."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il les niveaux de chimiokines CXC ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler les niveaux de chimiokines et améliorer la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les chimiokines CXC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente les niveaux de chimiokines et contribue à l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress chronique affecte-t-il les chimiokines CXC ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter l'expression des chimiokines et aggraver l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les chimiokines CXC ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques et des inhibiteurs de chimiokines sont en développement."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils les chimiokines CXC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression des chimiokines CXC dans l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les inhibiteurs de chimiokines CXC fonctionnent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils bloquent les récepteurs des chimiokines, réduisant ainsi l'inflammation et la migration cellulaire."
}
},
{
"@type": "Question",
"name": "Les traitements anti-inflammatoires influencent-ils les chimiokines CXC ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent moduler les niveaux de chimiokines et améliorer les symptômes inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques sur les chimiokines CXC ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant les chimiokines CXC."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des niveaux élevés de chimiokines CXC ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies auto-immunes, des infections chroniques et des cancers."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles impliquées dans le cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent favoriser la progression tumorale et la métastase dans certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CXC affectent-elles la cicatrisation des plaies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut retarder la cicatrisation en exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées aux chimiokines CXC ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de chimiokines sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC peuvent-elles causer des troubles neurologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans des troubles comme la sclérose en plaques et l'Alzheimer."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque augmentent les niveaux de chimiokines CXC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles influencer les chimiokines CXC ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections aiguës et chroniques peuvent augmenter l'expression des chimiokines."
}
},
{
"@type": "Question",
"name": "L'exposition à des polluants affecte-t-elle les chimiokines CXC ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des polluants environnementaux peut augmenter les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Le vieillissement influence-t-il les chimiokines CXC ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une augmentation des niveaux de chimiokines et de l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques sont-elles liées aux chimiokines CXC ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent augmenter les niveaux de chimiokines et l'inflammation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Publications dans "Chimiokines CXC" :
4 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Publications dans "Chimiokines CXC" :
3 publications dans cette catégorie
Affiliations :
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Dept. of Hematology, Faculty of Biomed, Biomedical Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Publications dans "Chimiokines CXC" :
3 publications dans cette catégorie
Affiliations :
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: mojgan.noroozi@yahoo.com.
Publications dans "Chimiokines CXC" :
3 publications dans cette catégorie
Affiliations :
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, USA.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Departments of Biological Sciences and of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.
Present address: Dept. of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Departments of Biological Sciences and of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning Province, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Aesthetic Medicine, Medical University of Bialystok, 15-267 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Internal Medicine, University of Patras Medical School, 26500 Patras, Greece.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Intensive Care Unit, Patras University Hospital, 26500 Patras, Greece.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiology, University Hospital of South Manchester, NHS Foundation Trust, Manchester M23 9LT, UK.
Publications dans "Chimiokines CXC" :
Listening to speech with poor signal quality is challenging. Neural speech tracking of degraded speech has been used to advance the understanding of how brain processes and speech intelligibility are ...
The purpose of the study is to investigate the impacts of a surgical mask and a transparent mask on audio-only and audiovisual speech intelligibility in noise (i.e., 0 dB signal-to-noise ratio) in ind...
Thirty-one individuals with hearing loss (from 22 to 74 years old) completed keyword identification tasks to measure face-masked speech intelligibility in noise. A mixed-effects logistic regression mo...
In the audio-only mode, the GHL group showed reduced speech intelligibility regardless of other factors, whereas the MHL group showed decreased speech intelligibility for the transparent mask more tha...
The findings indicate that, when using face masks, either a transparent mask or a surgical mask negatively affects speech understanding in noise for individuals with hearing loss. Using a transparent ...
This study sought to determine if alternative vowel space area (VSA) measures (i.e., novel trajectory-based measures: vowel space hull area and vowel space density) predicted speech intelligibility to...
The Grandfather Passage was read aloud by 40 speakers with dysarthria of varying etiologies, including Parkinson's disease (...
Traditional VSA was the sole significant predictor of speech intelligibility for both the OTs (...
The findings suggest that traditional token-based vowel measures better predict intelligibility than trajectory-based measures. Additionally, the findings suggest that VAS methods are comparable to OT...
Various types of methods and approaches are available to predict the intelligibility of speech signals, but many of these still suffer from two major problems: first, their required prior knowledge, w...
Speech perception is a probabilistic process, integrating bottom-up and top-down sources of information, and the frequency and phonological neighborhood of a word can predict how well it is perceived....
We measured the intelligibility of 165 children between 30 and 47 months in age on 38 different single words. We performed an item response analysis using generalized mixed-effects logistic regression...
There was considerable variation among the words and the children, but between-word variability was larger in magnitude than between-child variability. There was a clear positive effect of target word...
Word frequency and neighborhood competition both had an effect on intelligibility in young children's speech, so listener expectations are an important factor in the selection of items for children's ...
It is well known that speech uses both the auditory and visual modalities to convey information. In cases of congenital sensory deprivation, the feedback language learners have access to for mapping v...
Twenty adult listeners performed two perceptual identification tasks in which vowels produced by congenitally blind adults and sighted adults were used as stimuli. The vowels were presented in the aud...
The results showed that, although blind speakers did not differ from their sighted peers in the auditory modality, they had lower scores in the audiovisual and visual modalities. Some vowels produced ...
Together, the results suggest that adult blind speakers have learned to adapt to their sensory loss so that they can successfully achieve intelligible vowel targets in non-noisy conditions but that th...
The purpose of the current study is to explore listeners' perception of accented speech in terms of confidence and intelligence. To this end, three groups of listeners were asked to rate speakers of E...
Auditory rhythms are ubiquitous in music, speech, and other everyday sounds. Yet, it is unclear how perceived rhythms arise from the repeating structure of sounds. For speech, it is unclear whether rh...
This study investigated whether listener processing of dysarthric speech requires the recruitment of more cognitive resources (i.e., higher levels of listening effort) than neurotypical speech. We als...
A word recall paradigm was used to index behavioral listening effort. The primary task involved word transcription, whereas a memory task involved recalling words from previous sentences. Nineteen lis...
Results revealed significant effects of dysarthria on the likelihood of correct word recall, indicating that the transcription of dysarthric speech required higher levels of behavioral listening effor...
Results suggest that cognitive resources, particularly listeners' working memory capacity, are more taxed when deciphering dysarthric versus neurotypical speech. An increased demand on these resources...
There is increasing interest in using automatic speech recognition (ASR) systems to evaluate impairment severity or speech intelligibility in speakers with dysarthria. We assessed the clinical validit...
Using speech samples collected from 52 individuals with ALS and 20 healthy control speakers, we compared word recognition rate (WRR) from the commercially available Google Cloud ASR API (Machine WRR) ...
Human WRR achieved better accuracy than Machine WRR when indexing speech severity, and, although related, Human and Machine WRR were not strongly correlated. When the speech signal was mixed with nois...
Results indicated that the OTS ASR system was inadequate for early detection of speech impairment and grading overall speech severity. While Machine and Human WRR were correlated, ASR should not be us...